| SC 13G/A | 2024-02-13 | GILEAD SCIENCES, INC. | Allovir, Inc. | 16,635,286 | 14.6% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Allovir, Inc. | 5,692,782 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-09 | Artal International S.C.A. | Allovir, Inc. | 6,597,167 | 5.8% | EDGAR |
| SC 13G | 2024-02-01 | EcoR1 Capital, LLC | Allovir, Inc. | 10,655,366 | 9.3% | EDGAR |
| SC 13G/A | 2024-01-09 | Wilson John Robert | Allovir, Inc. | 5,355,877 | 4.7% | EDGAR |
| SC 13G | 2024-01-09 | Wilson John Robert | Allovir, Inc. | 5,562,954 | 9.0% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Allovir, Inc. | 7,046,373 | 7.6% | EDGAR |
| SC 13G | 2022-08-08 | GILEAD SCIENCES, INC. | Allovir, Inc. | 13,704,416 | 14.8% | EDGAR |
| SC 13D/A | 2022-08-05 | ElevateBio, LLC | Allovir, Inc. | 16,674,766 | 18.0% | EDGAR |
| SC 13D | 2022-08-05 | Globeways Holdings II Ltd | Allovir, Inc. | 2,059,884 | 2.2% | EDGAR |
| SC 13G | 2022-08-05 | Artal International S.C.A. | Allovir, Inc. | 5,577,167 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Allovir, Inc. | 7,381,063 | 11.3% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Allovir, Inc. | 7,177,546 | 11.0% | EDGAR |
| SC 13D | 2020-08-13 | ElevateBio, LLC | Allovir, Inc. | 13,420,970 | 20.6% | EDGAR |
| SC 13G | 2020-08-13 | Globeways Holdings II Ltd | Allovir, Inc. | 1,399,732 | 2.1% | EDGAR |
| SC 13G | 2020-08-10 | FMR LLC | Allovir, Inc. | 6,191,535 | 10.1% | EDGAR |